|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,357.00 GBX | +1.42% |
|
-6.15% | +14.42% |
| 17/07 | Utility stocks support FTSE 100 in nervy trade | AN |
| 17/07 | WINNERS & LOSERS: Vega ups Vodafone stake; GSK drug trial disappoints | AN |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -8.73 | -11.5 | 6.3 | 5.6 | 13.44 | |||||
Return on Total Capital | -8.74 | -11.52 | 6.36 | 5.65 | 13.47 | |||||
Return On Equity % | -16.03 | -22.26 | 11.32 | 9.86 | 23.95 | |||||
Return on Common Equity | -16.03 | -22.26 | 11.32 | 9.86 | 23.95 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 100 | 100 | 100 | 100 | 100 | |||||
SG&A Margin | -2.44 | -1.53 | 2.85 | 3.13 | 1.41 | |||||
EBITA Margin % | 102.44 | 101.53 | 97.15 | 96.87 | 98.59 | |||||
EBIT Margin % | 102.44 | 101.53 | 97.15 | 96.87 | 98.59 | |||||
Income From Continuing Operations Margin % | 106.11 | 106.6 | 94.48 | 93.24 | 97.38 | |||||
Net Income Margin % | 106.11 | 106.6 | 94.48 | 93.24 | 97.38 | |||||
Net Avail. For Common Margin % | 106.11 | 106.6 | 94.48 | 93.24 | 97.38 | |||||
Normalized Net Income Margin | 66.27 | 66.54 | 59.3 | 58.96 | 60.92 | |||||
Levered Free Cash Flow Margin | 65.81 | 65 | 54.93 | 58.46 | 61.33 | |||||
Unlevered Free Cash Flow Margin | 64.64 | 63.48 | 57.31 | 61.13 | 62.36 | |||||
Asset Turnover | ||||||||||
Asset Turnover | -0.14 | -0.18 | 0.1 | 0.09 | 0.22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.46 | 0.49 | 0.88 | 0.16 | 0.08 | |||||
Quick Ratio | 0.46 | 0.49 | 0.88 | 0.16 | 0.08 | |||||
Operating Cash Flow to Current Liabilities | -0.16 | -0.16 | -0.14 | -0.17 | -0.1 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 14.45 | 15.86 | 13.02 | 13.44 | 11.62 | |||||
Total Debt / Total Capital | 12.62 | 13.69 | 11.52 | 11.85 | 10.41 | |||||
LT Debt/Equity | 11.04 | 12.59 | 11.33 | 9.78 | 7.14 | |||||
Long-Term Debt / Total Capital | 9.65 | 10.86 | 10.02 | 8.63 | 6.4 | |||||
Total Liabilities / Total Assets | 12.75 | 13.85 | 12.95 | 12.09 | 10.62 | |||||
EBIT / Interest Expense | -55.01 | -41.78 | 25.55 | 22.72 | 59.59 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -125.83 | 14.32 | -152.74 | -9.66 | 143.88 | |||||
Gross Profit, 1 Yr. Growth % | -125.83 | 14.32 | -152.74 | -9.66 | 143.88 | |||||
EBITA, 1 Yr. Growth % | -126.6 | 13.31 | -150.47 | -9.93 | 148.21 | |||||
EBIT, 1 Yr. Growth % | -126.6 | 13.31 | -150.47 | -9.93 | 148.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -127.61 | 14.85 | -146.75 | -10.85 | 154.7 | |||||
Net Income, 1 Yr. Growth % | -127.61 | 14.85 | -146.75 | -10.85 | 154.7 | |||||
Normalized Net Income, 1 Yr. Growth % | -127.58 | 14.79 | -147 | -10.18 | 151.96 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -128.18 | 14.74 | -147.54 | -2.78 | 191.11 | |||||
Accounts Receivable, 1 Yr. Growth % | -51.41 | 10.62 | 2.35T | -74.16 | -37.48 | |||||
Total Assets, 1 Yr. Growth % | -7.46 | -21.08 | 8.71 | -5.27 | 12.52 | |||||
Tangible Book Value, 1 Yr. Growth % | -13.15 | -22.08 | 9.84 | -4.33 | 14.4 | |||||
Common Equity, 1 Yr. Growth % | -13.15 | -22.08 | 9.84 | -4.33 | 14.4 | |||||
Cash From Operations, 1 Yr. Growth % | 48.22 | -26.11 | -1.71 | 32.17 | -16.66 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -127.16 | 12.91 | -144.58 | -3.86 | 155.83 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -126.59 | 12.26 | -147.62 | -3.65 | 148.8 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.97 | 14.21 | 3.41 | 3.3 | 4.34 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 51.31 | -45.66 | -22.35 | -30.98 | 48.43 | |||||
Gross Profit, 2 Yr. CAGR % | 51.31 | -45.66 | -22.35 | -30.98 | 48.43 | |||||
EBITA, 2 Yr. CAGR % | 55.29 | -45.1 | -24.38 | -32.58 | 49.53 | |||||
EBIT, 2 Yr. CAGR % | 55.29 | -45.1 | -24.38 | -32.58 | 49.53 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 61.7 | -43.68 | -26.73 | -35.44 | 50.69 | |||||
Net Income, 2 Yr. CAGR % | 61.7 | -43.68 | -26.73 | -35.44 | 50.69 | |||||
Normalized Net Income, 2 Yr. CAGR % | 61.54 | -43.73 | -26.55 | -35.02 | 50.44 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 64.24 | -43.14 | -26.14 | -32.01 | 68.23 | |||||
Accounts Receivable, 2 Yr. CAGR % | -54.84 | -26.69 | 420.2 | 151.4 | -59.81 | |||||
Total Assets, 2 Yr. CAGR % | 35.83 | -14.54 | -7.38 | 1.48 | 3.24 | |||||
Tangible Book Value, 2 Yr. CAGR % | 33.78 | -17.73 | -7.48 | 2.51 | 4.61 | |||||
Common Equity, 2 Yr. CAGR % | 33.78 | -17.73 | -7.48 | 2.51 | 4.61 | |||||
Cash From Operations, 2 Yr. CAGR % | 64.59 | 4.65 | -14.78 | 13.98 | 4.95 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 64.55 | -44.63 | -29.06 | -34.54 | 56.83 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 60.42 | -45.37 | -26.89 | -32.27 | 54.83 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.1 | 9.49 | 8.68 | 3.36 | 3.82 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 36.07 | 37.81 | -46.2 | -18.33 | 5.13 | |||||
Gross Profit, 3 Yr. CAGR % | 36.07 | 37.81 | -46.2 | -18.33 | 5.13 | |||||
EBITA, 3 Yr. CAGR % | 38.45 | 39.8 | -46.62 | -19.84 | 4.11 | |||||
EBIT, 3 Yr. CAGR % | 38.45 | 39.8 | -46.62 | -19.84 | 4.11 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 42.29 | 44.27 | -47.07 | -21.78 | 2.01 | |||||
Net Income, 3 Yr. CAGR % | 42.29 | 44.27 | -47.07 | -21.78 | 2.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | 42.24 | 44.15 | -47.01 | -21.45 | 2.08 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 42.81 | 45.73 | -46.43 | -19.05 | 10.4 | |||||
Accounts Receivable, 3 Yr. CAGR % | -29.18 | -39.12 | 136.03 | 91.21 | 58.09 | |||||
Total Assets, 3 Yr. CAGR % | 27.49 | 13.34 | -7.41 | -6.68 | 5.03 | |||||
Tangible Book Value, 3 Yr. CAGR % | 25.7 | 11.72 | -9.41 | -6.45 | 6.33 | |||||
Common Equity, 3 Yr. CAGR % | 25.7 | 11.72 | -9.41 | -6.45 | 6.33 | |||||
Cash From Operations, 3 Yr. CAGR % | 54.58 | 26.03 | 2.49 | -1.35 | 2.68 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 41.81 | 45.14 | -48.49 | -21.49 | 3.11 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 39.42 | 42.42 | -47.81 | -19.84 | 4.51 | |||||
Dividend Per Share, 3 Yr. CAGR % | 4.68 | 8.05 | 7.43 | 6.85 | 3.68 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.65 | 17.31 | 8.72 | 4.51 | -19.26 | |||||
Gross Profit, 5 Yr. CAGR % | 11.65 | 17.31 | 8.72 | 4.51 | -19.26 | |||||
EBITA, 5 Yr. CAGR % | 12.48 | 18.09 | 8.7 | 4.43 | -19.4 | |||||
EBIT, 5 Yr. CAGR % | 12.48 | 18.09 | 8.7 | 4.43 | -19.4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.37 | 19.26 | 9.11 | 4.59 | -19.57 | |||||
Net Income, 5 Yr. CAGR % | 14.37 | 19.26 | 9.11 | 4.59 | -19.57 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.32 | 19.23 | 9.2 | 4.81 | -19.56 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.63 | 18.65 | 9.7 | 7.43 | -15.34 | |||||
Accounts Receivable, 5 Yr. CAGR % | -8.4 | 69.49 | 57.25 | 7.35 | 16.26 | |||||
Total Assets, 5 Yr. CAGR % | 25.69 | 14.83 | 12.19 | 8.44 | -3.29 | |||||
Tangible Book Value, 5 Yr. CAGR % | 24.8 | 13.19 | 11.19 | 7.94 | -4.04 | |||||
Common Equity, 5 Yr. CAGR % | 24.8 | 13.19 | 11.19 | 7.94 | -4.04 | |||||
Cash From Operations, 5 Yr. CAGR % | 51.82 | 45.5 | 21.82 | 21.06 | 3.46 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.94 | 18.59 | 7.5 | 5.55 | -19.59 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 13.2 | 17.61 | 7.69 | 5.8 | -19.37 | |||||
Dividend Per Share, 5 Yr. CAGR % | 3.66 | 5.96 | 6.26 | 6.15 | 5.97 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















